These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 3135644)
1. Studies on hemotoxicity of cyclophosphamide, doxorubicin and cis-diamminodichloroplatinum combined with sodium-2-mercaptoethane sulfonate. Lerza R; Bogliolo G; Mencoboni M; Saviane A; Pannacciulli I Tumori; 1988 Jun; 74(3):333-7. PubMed ID: 3135644 [TBL] [Abstract][Full Text] [Related]
2. Effect of diethyldithiocarbamate on toxicity of doxorubicin, cyclophosphamide and cis-diamminedichloroplatinum (II) on mice haemopoietic progenitor cells. Pannacciulli IM; Lerza RA; Bogliolo GV; Mencoboni MP; Saviane AG Br J Cancer; 1989 Mar; 59(3):371-4. PubMed ID: 2539178 [TBL] [Abstract][Full Text] [Related]
3. Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna). Brock N; Pohl J; Stekar J; Scheef W Eur J Cancer Clin Oncol; 1982 Dec; 18(12):1377-87. PubMed ID: 6819957 [TBL] [Abstract][Full Text] [Related]
4. Comparison of reduced glutathione with 2-mercaptoethane sulfonate to prevent cyclophosphamide-induced urotoxicity. Cavalletti E; Tofanetti O; Zunino F Cancer Lett; 1986 Jul; 32(1):1-6. PubMed ID: 3091245 [TBL] [Abstract][Full Text] [Related]
5. Interaction of Mesna (2-mercaptoethane sulfonate) with the mutagenicity of cyclophosphamide in vitro and in vivo. Lähdetie J; Räty R; Sorsa M Mutat Res; 1990 Sep; 245(1):27-32. PubMed ID: 2118231 [TBL] [Abstract][Full Text] [Related]
6. In vitro/in vivo effects of Mesna on the genotoxicity and toxicity of cyclophosphamide--a study aimed at clarifying the mechanism of Mesna's anticarcinogenic activity. Pool BL; Bos RP; Niemeyer U; Theuws JL; Schmähl D Toxicol Lett; 1988 Apr; 41(1):49-56. PubMed ID: 3128896 [TBL] [Abstract][Full Text] [Related]
8. Protective effect of sodium-2-mercaptoethanesulfonate on the gastrointestinal toxicity and lethality of cis-diamminedichloroplatinum. Allan SG; Smyth JF; Hay FG; Leonard RC; Wolf CR Cancer Res; 1986 Jul; 46(7):3569-73. PubMed ID: 3085925 [TBL] [Abstract][Full Text] [Related]
9. [Prevention of tumor formation in the bladder by sodium-2-mercaptoethane sulfonate (mesna). Experimental studies and clinical consequences]. Schmähl D; Habs M; Tacchi AM Urologe A; 1984 Sep; 23(5):291-6. PubMed ID: 6438859 [TBL] [Abstract][Full Text] [Related]
10. [Prevention of urotoxic actions of cyclophosphamide and ifosfamide by dimesna (preliminary communication) (author's transl)]. Brock N; Stekar J Arzneimittelforschung; 1982; 32(5):486-7. PubMed ID: 6809014 [TBL] [Abstract][Full Text] [Related]
11. The prevention of cyclophosphamide-induced bladder swelling in the rat by I.V. administration of sodium-2-mercaptoethane sulfonate. Kedar A; Simpson CL; Williams P; Moore R; Tritsch G; Murphy GP Res Commun Chem Pathol Pharmacol; 1980 Aug; 29(2):339-48. PubMed ID: 6774389 [TBL] [Abstract][Full Text] [Related]
12. Effects of fosfomycin, mesna, and sodium thiosulfate on the toxicity and antitumor activity of cisplatin. Wagner T; Kreft B; Bohlmann G; Schwieder G J Cancer Res Clin Oncol; 1988; 114(5):497-501. PubMed ID: 3141427 [TBL] [Abstract][Full Text] [Related]
13. Effect of the uroprotector sodium 2-mercaptoethane sulfonate (Mesna) on the proliferation of the bladder urothelium in the rat after administration of cyclophosphamide. Kunze E; Köhnecke B; Engelhardt W; Steinröder H; Brock N; Pohl J Urol Int; 1984; 39(2):61-7. PubMed ID: 6426112 [TBL] [Abstract][Full Text] [Related]
14. Nephrotoxicity and carcinogenic risk of cis-platin (CDDP) prevented by sodium 2-mercaptoethane-sulfonate (Mesna): experimental results. Kempf SR; Ivankovic S Cancer Treat Rev; 1987 Dec; 14(3-4):365-72. PubMed ID: 3125972 [No Abstract] [Full Text] [Related]
15. Arginine 2-mercaptoethane sulfonate and sodium 2-mercaptoethane sulfonate: a comparative study of their effects upon tumour cells. Magnolfi Zipoli G; D'Ancona S; Berti T Drugs Exp Clin Res; 1988; 14(7):473-8. PubMed ID: 3149236 [TBL] [Abstract][Full Text] [Related]
16. Effective prevention of the nephrotoxicity of cis-platin (CDDP) by administration of sodium 2-mercaptoethane-sulfonate (MESNA) in rats. Kempf SR; Ivankovic S; Wiessler M; Schmähl D Br J Cancer; 1985 Dec; 52(6):937-9. PubMed ID: 3935152 [No Abstract] [Full Text] [Related]
18. The use of sodium 2-mercaptoethane sulfonate to prevent cyclophosphamide cystitis. Ehrlich RM; Freedman A; Goldsobel AB; Stiehm ER J Urol; 1984 May; 131(5):960-2. PubMed ID: 6423841 [TBL] [Abstract][Full Text] [Related]
19. [Autoradiographic studies on the protective effect of mesna in the urinary bladder mucosa of the rat during administration of cyclophosphamide (preliminary communication)]. Kunze E; Köhnecke B; Engelhardt W; Brock N; Pohl J Arzneimittelforschung; 1983; 33(6):853-4. PubMed ID: 6412725 [TBL] [Abstract][Full Text] [Related]